Benzinga | Jul 27, 2021 11:13AM EDT

Piper Sandler Maintains Overweight on Edwards Lifesciences, Raises Price Target to $120

Piper Sandler analyst Adam Maeder maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $105 to $120.